BUND FINANCE › Stocks › CAH
Cardinal Health, Inc. (CAH)
NYSE · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed
Key stats
Quick technical read
- Price is +13.28% above its 50-day average.
- It is +23.29% above its 200-day average (long-term uptrend).
- It sits at 92% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | US$181.3B | US$205.0B | US$226.8B | US$222.6B | US$254.2B |
| Net income | −US$938.0M | US$330.0M | US$852.0M | US$1.6B | US$1.7B |
| EPS (diluted) | -3.34 | 1.26 | 3.45 | 6.45 | 7.23 |
| Gross margin | 3.6% | 3.4% | 3.3% | 3.7% | 3.8% |
| Operating margin | -0.3% | 0.4% | 0.6% | 1.0% | 1.0% |
| Net margin | -0.5% | 0.2% | 0.4% | 0.7% | 0.7% |
| Free cash flow | US$2.7B | US$2.4B | US$3.3B | US$1.9B | US$4.5B |
| Total debt | US$5.8B | US$5.2B | US$5.6B | US$9.3B | US$9.9B |
| Cash | US$4.7B | US$4.1B | US$5.1B | US$3.9B | US$4.9B |
Compound annual growth: revenue 8.8% · net income — (4 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | 36.0x | 40.4x | 27.1x |
| EV / EBITDA | 19.0x | 69.5x | 16.5x |
| Operating margin | 1.1% | — | 3.6% |
| Net margin | 0.7% | — | -0.0% |
| Debt / equity | — | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segmen…
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice